Weight Management

Men and those who are overweight at greater risk.

Antidepressants are commonly used medications, with about 16% of people in Canada using antidepressants in 2023.

Eli Lilly anticipates that Zepbound (tirzepatide) will be available in the KwikPen format this summer.

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

To coincide with the release on Canada’s new guidelines for obesity in children, Obesity Canada is offering a new free introductory course on pediatric obesity care.

Later first pregnancy was also shown to be a risk factor as was postmenopausal weight gain.